Skip to main content

and
  1. Article

    Open Access

    Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

    SB3, a biosimilar of Herceptin® (trastuzumab, hereinafter referred to as reference product) is currently approved in the EU, Korea, Australia, the USA, and Brazil for the treatment of human epidermal growth facto...

    Kyungyeol Paek, Go-woon Kim, So Yeong Ahn, Joon Hyuk Lim, Dongkeum Jung in BioDrugs (2019)